Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T19:13:00.943Z.
Calculation as of: 2026-10-06T19:13:00.943Z.
Quote observation: 2026-10-06T19:08:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$77.02M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.65M
Price/OCF Ratio
N/A
TTM Avg
786.57
3Y Avg
786.57
5Y Avg
786.57
Market Cap
$76.27M
Price/OCF Ratio
3.47
TTM Avg
3.93
3Y Avg
19.17
5Y Avg
19.17
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | $77.30M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.38M | N/A | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.02M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $76.65M | N/A | 786.57 | 786.57 | 786.57 |
| SkinHealth Systems Inc. (SKIN)vs › | $76.27M | 3.47 | 3.93 | 19.17 | 19.17 |
| Pulmonx Corporation (LUNG)vs › | $75.82M | N/A | N/A | N/A | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $79.09M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $75.41M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
